Treatment of muscle-invasive bladder cancer

Amir Sherif, Martin N. Jonsson, N. Peter Wiklund

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

In the USA, the incidence of bladder cancer is three-times higher in men than in women and it is the fourth most common cancer in men after prostate, lung and colorectal cancer. Muscle-invasive urothelial urinary bladder cancer has a very high mortality rate, This is regardless of intensive therapeutic efforts such as radical surgery in combination with oncological treatment options. The development of treatments with better outcomes regarding disease-specific survival and treatment-inflicted morbidity is likely to occur over the next few years. The significance of meta-analyses on the effect of neoadjuvant chemotherapy, the development of sentinel node dissection and the impact of the introduction of robot-assisted surgery on the possibility of performing minimally invasive surgery in advanced bladder cancer patients is discussed.

Original languageEnglish
Pages (from-to)1279-1283
Number of pages5
JournalExpert Review of Anticancer Therapy
Volume7
Issue number9
DOIs
StatePublished - Sep 2007
Externally publishedYes

Keywords

  • Bladder cancer
  • DaVinci
  • Extended lymph node dissection
  • Minimally invasive cystectomy
  • Neoadjuvant chemotherapy
  • Robot-assisted surgery
  • Sentinel node detection

Fingerprint

Dive into the research topics of 'Treatment of muscle-invasive bladder cancer'. Together they form a unique fingerprint.

Cite this